Project Grant DP2CA290196
Award Date
9/1/23
Completion Date
8/31/26
Dollars Obligated
$1.6M
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Cancer Institute
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
This $126,830 Project Grant award from the National Human Genome Research Institute (NHGRI) under the Human Genome Research Federal Grant Program (CFDA 93.172) supports the development of a somatic mutation-resolved lineage tracing system. The key objectives are to: 1) reconstruct single-cell genealogical trees coupled with detection of somatic mutations and epigenetic alterations; 2) trace somatic mutation acquisition histories on hematopoietic stem cell genealogical architecture and chart...
The federal Project Grant award in the amount of $617,367 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award is being used by the Children's Hospital Corporation, doing business as Boston Children's Hospital, to conduct research on "BASE EDITING TO IMPROVE CONDITIONING AND TRANSPLANT OF BONE MARROW FAILURE PATIENTS". The research project aims to leverage innovative gene editing techniques to enhance the...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, provides $249,645 in funding from January 1, 2025 to December 31, 2026 to develop advanced genetic engineering techniques to unravel the role of tumor-specific B cell responses in cancer progression. The project aims to exploit an optimized B cell gene editing protocol to redirect the specificity of...
The federal Project Grant award of $1,067,418.00 was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award is being used by The Children's Hospital Corporation, doing business as Boston Children's Hospital, to conduct research on "ACTIVATING GASDERMIN PORES TO INDUCE PYROPTOSIS AND ANTITUMOR IMMUNITY IN OVARIAN CANCERS". The research project aims to explore innovative approaches to...
This federal Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $3,834,112 to develop and refine computational tools to advance the safety and efficacy of genome editing. The key products and services to be delivered include: Enhancing the CRISPRME tool to better predict off-target effects of genome editing across diverse human genomes. A new tool, CRISPRUS, will also be developed to leverage variation graphs, complete genomes,...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,416,000 Project Grant to The Children's Hospital Corporation (Boston Children's Hospital), a non-profit teaching hospital and research center affiliated with Harvard Medical School. The grant, titled "IND-ENABLING STUDIES OF POLYMERASE INHIBITORS FOR BMF DUE TO TELOMERE EXHAUSTION", will support a 2-year research project from Sep 1, 2023 to Aug 31, 2025. Through this funding, Boston...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $796,500 project grant to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to investigate clonal evolution in Fanconi anemia. The grant period runs from September 30, 2023 to September 29, 2026. As a non-profit pediatric teaching hospital and research center, Boston Children's Hospital will leverage its expertise in pediatric medicine, genomics, and...
This $695,464 Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) to Boston Children's Hospital aims to integrate genomic and epigenomic data to pinpoint causal genetic variants associated with childhood B-cell acute lymphoblastic leukemia (B-ALL) risk. The key products and services to be delivered under this 5-year project include: Conducting a large, multi-ancestry genome-wide association study (GWAS) of childhood B-ALL, followed by statistical...
This $716,587 Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) aims to advance equity in rare disease genomic research. The grant recipient, The Children's Hospital Corporation (doing business as Boston Children's Hospital), will develop and implement a Diversity, Equity, and Inclusion Toolkit within their Rare Genomes Project to enhance participation of historically underrepresented populations. This hybrid...
The Department of Defense's Defense Health Agency has awarded a $1,258,719 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The grant, awarded on July 15, 2024, will support a 3-year research project titled "Melanoma Chemoprevention via Neuropilin-2 Axis Blockade." Through this grant, Boston Children's Hospital will conduct biomedical research focused on...